retatrutide peptide clinical trial Retatrutide vs Tirzepatide (2026): Differences

The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE/ and LDLr/ mice by a mechanism that includes inflammatory pathways

AMG 133 (maridebart cafraglutide) is a bispecific molecule engineered by conjugating a fully human monoclonal anti-human GIPR antagonist antibody to two GLP-1 analogue agonist peptides using amino acid linkers

These can include nausea, constipation, diarrhea, reflux, bloating, decreased appetite, abdominal discomfort, or vomiting

People who are most likely to benefit from a GLP-1 RA are sometimes the least likely [archived link] to have access to them

Neuropharmacology (2014) 76:5767

To identify POMC neurons and GLP-1 receptor-positive neurons, POMC humanized Renilla green fluorescent protein (hrGFP) (The Jackson Laboratory, 006421) and GLP-1 receptor cre::tdTomato (The Jackson Laboratory, 029283) mice were used